Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis

Dweck, 2011, Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis, J Am Coll Cardiol, 58, 1271, 10.1016/j.jacc.2011.03.064

Green, 2012, Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy, J Am Coll Cardiol Imag, 5, 370, 10.1016/j.jcmg.2011.11.021

Gulati, 2013, Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy, JAMA, 309, 896, 10.1001/jama.2013.1363

Hein, 2003, Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms, Circulation, 107, 984, 10.1161/01.CIR.0000051865.66123.B7

Díez, 2002, Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients, Circulation, 105, 2512, 10.1161/01.CIR.0000017264.66561.3D

Lopez, 2010, Circulating biomarkers of collagen metabolism in cardiac diseases, Circulation, 121, 1645, 10.1161/CIRCULATIONAHA.109.912774

Krayenbuehl, 1989, Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement, Circulation, 79, 744, 10.1161/01.CIR.79.4.744

Mewton, 2011, Assessment of myocardial fibrosis with cardiovascular magnetic resonance, J Am Coll Cardiol, 57, 891, 10.1016/j.jacc.2010.11.013

Messroghli, 2007, Myocardial T1 mapping: Application to patients with acute and chronic myocardial infarction, Magn Reson Med, 58, 34, 10.1002/mrm.21272

Bull, 2013, Human non-contrast T1 values and correlation with histology in diffuse fibrosis, Heart, 99, 932, 10.1136/heartjnl-2012-303052

Karamitsos, 2013, Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis, J Cardiovasc Magn Reson, 6, 488

Iles, 2008, Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping, J Am Coll Cardiol, 52, 1574, 10.1016/j.jacc.2008.06.049

Sibley, 2012, T1 mapping in cardiomyopathy at cardiac MR: Comparison with endomyocardial biopsy, Radiology, 265, 724, 10.1148/radiol.12112721

Flacke, 2001, Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction, Radiology, 218, 703, 10.1148/radiology.218.3.r01fe18703

Ugander, 2012, Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology, Eur Heart J, 33, 1268, 10.1093/eurheartj/ehr481

Kellman, 2012, Extracellular volume fraction mapping in the myocardium, part 1: Evaluation of an automated method, J Cardiovasc Magn Reson, 14, 63, 10.1186/1532-429X-14-63

Flett, 2010, Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: Preliminary validation in humans, Circulation, 122, 138, 10.1161/CIRCULATIONAHA.109.930636

White, 2013, T1 Mapping for Myocardial Extracellular Volume Measurement by CMR: Bolus only versus primed infusion technique, J Am Coll Cardiol Imag, 6, 955, 10.1016/j.jcmg.2013.01.011

Flett, 2012, Diffuse myocardial fibrosis in severe aortic stenosis: An equilibrium contrast cardiovascular magnetic resonance study, Eur Heart J Cardiovas Imaging, 33, 819, 10.1093/ehjci/jes102

Miller, 2013, Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume, Circ Cardiovasc Imaging, 6, 373, 10.1161/CIRCIMAGING.112.000192

Kawel, 2012, T1 mapping of the myocardium: Intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA, J Cardiovasc Magn Reson, 14, 26, 10.1186/1532-429X-14-26

Kawel, 2012, T1 mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region, J Cardiovasc Magn Reson, 14, 27, 10.1186/1532-429X-14-27

Piechnik, 2010, Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3T within a 9 heartbeat breathhold, J Cardiovasc Magn Reson, 12, 69, 10.1186/1532-429X-12-69

Liu, 2012, Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: Sample size considerations for clinical trials, J Cardiovasc Magn Reson, 14, 90, 10.1186/1532-429X-14-90

Oshinski, 2010, Cardiovascular magnetic resonance at 3.0T: Current state of the art, J Cardiovasc Magn Reson, 12, 55, 10.1186/1532-429X-12-55

Baumgartner, 2009, Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice, J Am Soc Echocardiogr, 22, 1, 10.1016/j.echo.2008.11.029

Xue, 2012, Motion correction for myocardial T1 mapping using image registration with synthetic image estimation, Magn Reson Med, 67, 1644, 10.1002/mrm.23153

Huber, 2007, Phase-sensitive inversion recovery single-shot balanced steady-state free precession for detection of myocardial infarction during a single breathhold, Acad Radiol, 14, 1500, 10.1016/j.acra.2007.06.017

Simonetti, 2001, An improved MR imaging technique for the visualization of myocardial infarction, Radiology, 218, 215, 10.1148/radiology.218.1.r01ja50215

Cerqueira, 2002, Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association, Circulation, 105, 539, 10.1161/hc0402.102975

Portney, 2009

Gai, 2010, T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison, Magn Reson Med, 65, 1407, 10.1002/mrm.22716

Dweck, 2012, Calcific aortic stenosis: a disease of the valve and the myocardium, J Am Coll Cardiol, 60, 1854, 10.1016/j.jacc.2012.02.093

Sado, 2012, Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease, Heart, 98, 1436, 10.1136/heartjnl-2012-302346